1. Home
  2. FLO vs AGIO Comparison

FLO vs AGIO Comparison

Compare FLO & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowers Foods Inc.

FLO

Flowers Foods Inc.

HOLD

Current Price

$8.00

Market Cap

1.9B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.12

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLO
AGIO
Founded
1919
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
FLO
AGIO
Price
$8.00
$28.12
Analyst Decision
Hold
Buy
Analyst Count
5
8
Target Price
$11.20
$38.88
AVG Volume (30 Days)
7.1M
874.1K
Earning Date
05-15-2026
04-29-2026
Dividend Yield
11.16%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$5,256,479,000.00
$43,011,000.00
Revenue This Year
N/A
$76.75
Revenue Next Year
$0.65
$170.73
P/E Ratio
$17.58
N/A
Revenue Growth
3.00
N/A
52 Week Low
$6.80
$22.24
52 Week High
$17.24
$46.00

Technical Indicators

Market Signals
Indicator
FLO
AGIO
Relative Strength Index (RSI) 48.63 47.67
Support Level $7.86 $26.42
Resistance Level $8.94 $29.37
Average True Range (ATR) 0.41 0.95
MACD -0.06 0.18
Stochastic Oscillator 56.62 59.55

Price Performance

Historical Comparison
FLO
AGIO

About FLO Flowers Foods Inc.

Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: